Sanofi announces insulin price cap after actions by Eli Lilly and Novo Nordisk
Thank you President Biden. I used the long lasting insulin from this company
https://www.nbcnews.com/health/health-news/sanofi-insulin-price-cap-rcna75346
Sanofi will cap the out-of-pocket cost of its most popular insulin, Lantus, at $35 per month for people with private insurance, the French drugmaker said Thursday. The change will take effect Jan. 1, 2024.
Sanofi is the last of three major insulin makers in the United States to cut or cap the price of the drug.
Both Eli Lilly and Novo Nordisk announced changes to how they price their insulin this month. Together, the three drugmakers make up roughly 90% of the insulin market in the U.S.
"It seemed like only a matter of time" before Sanofi also made changes, said Stacie Dusetzina, a health policy professor at Vanderbilt University Medical Center in Nashville, Tennessee. "You dont want to be a standout.